DT
Drive Therapeutics is developing targeted gene therapies to treat retinal diseases, focusing on restoring vision by addressing the underlying genetic causes. The company aims to improve patient outcomes by providing precise, long-lasting treatments that reduce the progression of vision loss.
Updated 20 months ago
Funding
$100K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ONFunding rounds are not available yet.
Founders
Product
Features
- Drive Therapeutics is developing targeted gene therapies to treat retinal diseases, focusing on restoring vision by addressing the underlying genetic causes. The company aims to improve patient outcomes by providing precise, long-lasting treatments that reduce the progression of vision loss.